-+ 0.00%
-+ 0.00%
-+ 0.00%

VOR BIOPHARMA INC: TELITACICEPT WAS GENERALLY WELL TOLERATED THROUGH 48 WEEKS WITH NO NEW SAFETY SIGNALS OBSERVED

Reuters·09/29/2026 12:05:31

Please log in to view news